Company Profile

NuVasive, Inc. is a medical technology company. The Company is focused on developing, manufacturing, selling and providing procedural solutions for spine surgery, with a guiding purpose to transform surgery, advance care and change lives. It offers a portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. In addition, it develops and sells magnetically adjustable implant systems for the spine and specialized orthopedic procedures. It also designs and sell expandable growing rod implant systems for the treatment of early-onset scoliosis that can be non-invasively lengthened after implantation with incremental adjustments via an external remote controller using magnetic technology called MAGneticExternal Control (MAGEC). It operates in more than 50 countries serving surgeons, hospitals, and patients.

Employees

3,000

Sector

Medical Equipment, Supplies & Distribution

More about the company

07/09/23	Globus Medical Launches Precice Bone Transport in Select Markets	MT
04/09/23	NuVasive, Inc.(NasdaqGS:NUVA) dropped from NASDAQ Composite Index	CI
01/09/23	Globus Medical Completes Merger With NuVasive	MT
01/09/23	NuVasive, Inc.(NasdaqGS:NUVA) dropped from S&P 600 Health Care	CI
01/09/23	NuVasive, Inc.(NasdaqGS:NUVA) dropped from S&P 600	CI
01/09/23	NuVasive, Inc.(NasdaqGS:NUVA) dropped from S&P Healthcare Equipment Select Industry Index	CI
01/09/23	NuVasive, Inc.(NasdaqGS:NUVA) dropped from S&P Composite 1500	CI
01/09/23	NuVasive, Inc.(NasdaqGS:NUVA) dropped from S&P TMI Index	CI
01/09/23	NuVasive, Inc.(NasdaqGS:NUVA) dropped from S&P 1000	CI
01/09/23	NuVasive, Inc.(NasdaqGS:NUVA) dropped from S&P Global BMI Index	CI
01/09/23	Globus Medical, Inc. completed the acquisition of NuVasive, Inc. from BlackRock, Inc., The Vanguard Group, Inc., Thrivent Financial for Lutherans and others for $2.6 billion.	CI
29/08/23	Goosehead Insurance, Jackson Financial Advance Amid Addition to S&P SmallCap 600	MT
29/08/23	Goosehead Insurance, Jackson Financial to be Added to S&P SmallCap 600	MT

04/08/23	Barclays Adjusts Price Target on NuVasive to $58 From $56, Maintains Overweight Rating	MT
19/07/23	Truist Securities Adjusts Price Target on NuVasive to $51 From $48, Maintains Hold Rating	MT
31/05/23	Morgan Stanley Adjusts Price Target on NuVasive to $40 From $43, Keeps Equalweight Rating	MT
12/05/23	Barclays Adjusts Price Target on NuVasive to $56 From $53, Maintains Overweight Rating	MT
11/05/23	Morgan Stanley Adjusts Price Target on NuVasive to $43 From $44.50, Maintains Equal-Weight Rating	MT

30/08/23	NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting	PR
02/08/23	NuVasive: Q2 Earnings Snapshot	AQ
02/08/23	NuVasive : Second Quarter 2023 Release	PU
02/08/23	NuVasive : Second Quarter 2023 Supplemental Financials	PU
02/08/23	NuVasive Announces Second Quarter 2023 Financial Results	PR

19/07/23	Les valeurs à suivre aujourd'hui à la Bourse de Paris - Mercredi 19 juillet 2023
18/07/23	Les valeurs à suivre demain à la Bourse de Paris - Mercredi 19 juillet 2023
18/07/23	Smaio : publie un chiffre d'affaires semestriel en hausse de 203% sur un an
08/06/23	En Direct des Marchés : Airbus, Saint-Gobain, Soitec, Catana, Solocal, Vodafone, Novartis, GameStop...
08/06/23	Le retour du Faucon ?

Manager	Title	Age	Since
Daniel Scavilla CEO	Chief Executive Officer	61	-
Keith Pfeil DFI	Director of Finance/CFO	47	01/09/2023
Ryan Donahoe CTO	Chief Tech/Sci/R&D Officer	-	01/09/2021

NuVasive, Inc. Stock

Stocks

NUVA

US6707041058

Medical Equipment, Supplies & Distribution

Latest news : NuVasive, Inc.

Analysts' recommendations: NuVasive, Inc.

Press Releases: NuVasive, Inc.

News in other languages: NuVasive, Inc.

Quotes and Performance

Managers and Directors: NuVasive, Inc.

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Company Profile

Director	Title	Age	Since
Keith Pfeil BRD	Director/Board Member	47	01/09/2023
Daniel Scavilla BRD	Director/Board Member	61	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
9/1/23 A	Michael Farrington	Issuer sale	Public Communications Manager	33,983	0.0648%
9/1/23 A	John DeFord	Issuer sale	Director	20,771	0.0396%
9/1/23 A	James Barry	Issuer sale	Chief Executive Officer	361,817	0.6898%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NUVASIVE, INC.	-2.24%	+1.48%	-	-	2.08B
ABBOTT LABORATORIES	+0.17%	+3.13%	-13.36%	+10.47%	198B
MEDTRONIC PLC	-1.48%	+2.36%	-0.54%	+13.61%	120B
CENCORA, INC.	-0.29%	+2.16%	+4.28%	+74.99%	60.51B
HOYA CORPORATION	-0.69%	-2.96%	+27.89%	+63.21%	53.64B
BECTON, DICKINSON AND COMPANY	+0.52%	+3.47%	-5.48%	-31.68%	51.1B
DEXCOM, INC.	+0.23%	-1.80%	+9.99%	-14.19%	33.92B
MEDLINE INC.	-3.20%	-7.49%	-	-	29.75B
WEST PHARMACEUTICAL SERVICES, INC.	+0.71%	+2.78%	+44.40%	-9.40%	24.83B
TERUMO CORPORATION	+4.23%	-0.85%	-7.52%	+24.92%	23.01B
Average	-0.22%	-0.28%	+7.46%	+16.49%	66.14B
Weighted average by Cap.	-0.30%	+1.42%	+0.06%	+17.48%